Mathieu Petitjean, Ph.D.

Fibrosis Digital Pathology and AI, CEO, PharmaNest

Princeton, New Jersey, United States

About

Mathieu Petitjean is an experienced operational leader with 25 years of executive-level and international business experience in Healthcare Diagnostics Imaging, Digital Pathology and IT- based Medical Technologies. He is Founder and Board Member of the French-American Piano Society and a Member of several International Medical Societies.

Experience

  • Founder and CEO at PharmaNest
    Oct 2018 - Present · 7 yrs 10 mos

    PharmaNest develops and validates new Digital Pathology biomarkers for the quantification of fibrosis and Inflammation

  • Founder President at French-American Piano Society
    Aug 2014 - Present · 12 yrs

  • President at MedNest
    Jan 2007 - Oct 2018 · 11 yrs 10 mos

    MedNest sources and develops the business of innovative Medical Technology companies for the US markets, exclusively in the Drug – Devices and Diagnostic – Healthcare IT and Services convergence space, to accelerate disruptive changes in the US Healthcare System.

  • Director, Global Services Marketing at GE Water & Process Technologies
    Jan 2003 - Dec 2006 · 4 yrs

  • GE Healthcare, General Electric (7 yrs 9 mos)
    • Business Operations Director
      Aug 2000 - Sep 2003 · 3 yrs 2 mos

      Directly responsible for the commercial and business performance of the $280M, 535 employees North-East Service Business Unit

    • Multivendor Services Operations Manager
      May 1999 - Oct 2000 · 1 yr 6 mos

      GE HealthCare pioneered Multivendor Services in the HealthCare industry, which benefited from an extremely rapid growth: from $30M in 1997 to $180M in 2001.

    • European Customer Remote Support Center Manager
      Jan 1997 - Apr 1999 · 2 yrs 4 mos

      Hub of the European Services Operation for customer care, technical support and field services productivity for Europe, Russia and the Middle East.